BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33108125)

  • 21. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
    Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
    J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
    Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
    World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study.
    Huang ZN; Desiderio J; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
    BMC Gastroenterol; 2019 Dec; 19(1):205. PubMed ID: 31791240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.
    Jiang Y; Li T; Liang X; Hu Y; Huang L; Liao Z; Zhao L; Han Z; Zhu S; Wang M; Xu Y; Qi X; Liu H; Yang Y; Yu J; Liu W; Cai S; Li G
    JAMA Surg; 2017 Jul; 152(7):e171087. PubMed ID: 28538950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of surgery in patients aged 85 years or older with resectable gastric cancer: a propensity score matching analysis of the SEER database.
    Guo J; Yu J; Xu Z; Sun X; Zheng J
    Scand J Gastroenterol; 2020 Jun; 55(6):694-700. PubMed ID: 32459113
    [No Abstract]   [Full Text] [Related]  

  • 26. Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years?
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Eur J Surg Oncol; 2019 Jun; 45(6):1115-1120. PubMed ID: 30661920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study.
    Yeh JM; Tramontano AC; Hur C; Schrag D
    Gastric Cancer; 2017 Sep; 20(5):811-824. PubMed ID: 28205057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of marital status on the stage at diagnosis, treatment, and survival of adult patients with gastric cancer: a population-based study.
    Zhang J; Gan L; Wu Z; Yan S; Liu X; Guo W
    Oncotarget; 2017 Apr; 8(14):22385-22405. PubMed ID: 26894860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution.
    Wu HL; Tian Q; Peng CW; Liu SP; Li Y
    Asian Pac J Cancer Prev; 2011; 12(12):3341-5. PubMed ID: 22471477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
    Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
    World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer.
    Greenleaf EK; Kulaylat AN; Hollenbeak CS; Almhanna K; Wong J
    Ann Surg Oncol; 2016 Dec; 23(13):4203-4213. PubMed ID: 27459982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological Characteristics and Prognoses of Elderly Gastric Cancer Patients after R0 Resection: A Multicenter Study in China.
    Ma X; Ren D; Kan J; Zheng F; Zhang S; Zhang Y; Li Y; Liu Z; Ye L; Shen G; Wang Z; Zhao F; Ahmad R; Zhao J
    J Environ Pathol Toxicol Oncol; 2018; 37(1):81-91. PubMed ID: 29773002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
    Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
    J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marital status and survival in patients with gastric cancer.
    Jin JJ; Wang W; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Huang H; Wang YN
    Cancer Med; 2016 Aug; 5(8):1821-9. PubMed ID: 27264020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
    Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
    J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
    Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
    J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of efficacy in adjuvant chemotherapy regimens in patients with radically resected gastric cancer : a propensity-matched analysis.
    Quan R; Huang J; Chen H; Liao Y; Lv W; Chen N; Liu J; Zhang H; Xu D
    Oncotarget; 2016 Nov; 7(46):76316-76326. PubMed ID: 27602756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
    Altman AM; Sheka AC; Marmor S; Lou E; Reynolds M; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
    Surg Oncol; 2020 Sep; 34():134-139. PubMed ID: 32891318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.